Overview

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
This study examined the effects of two commonly prescribed HIV drugs on the way the body metabolizes glucose, insulin and fat.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Atazanavir Sulfate
HIV Protease Inhibitors
Lopinavir
Protease Inhibitors
Ritonavir